The inhibition of PTPRZ attenuates the malignant properties of glioblastoma cells, including cell proliferation and migration in vitro and tumor formation in vivo6, 22, 23, suggesting that the inhibition of PTPRZ is a potential strategy for the treatment of malignant gliomas. This evidence concerns the gene PTPRZ1 and glioblastoma.